JAK2 and lung carcinoma: FUZ is a critical regulator of cilia structure, whose expression is associated with poor prognosis in lung cancer patients; this effect of FUZ is mediated through the activation of ERK1/2 and JAK2/STAT3 signaling via the formation of the FUZ–BNIP3 complex [103].